Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer

Clinical trial NCT01546987 · COMPLETED

Trial details

NCT number: NCT01546987
Sponsor: Radiation Therapy Oncology Group
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2012-05-01
Primary completion: 2021-11-01
Enrollment: 239

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.